Modifying the Diffusion Layer of Soluble Salts of Poorly Soluble Basic Drugs To Improve Dissolution Performance

被引:44
作者
Hawley, Michael [1 ]
Morozowich, Walter [1 ]
机构
[1] Pfizer Inc, Groton, CT 06340 USA
关键词
Dissolution; precipitation; supersaturation; salts; diffusion layer; UNBUFFERED CONDITIONS; DELAVIRDINE MESYLATE; FORMS; MODEL; PH; FORMULATION; INHIBITION; HYDROLYSIS; SOLUBILITY; ABSORPTION;
D O I
10.1021/mp100117k
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The dissolution mechanism of soluble salts of poorly soluble bases can be complex because both the dissolution of the salt and precipitation of the free base can occur depending on the experimental conditions and properties of the molecule. The dissolution of three soluble salts of poorly soluble bases is described in this paper. Two of these compounds precipitate as free base under normal stomach pH conditions (pH from 2-4) during dissolution. This free base precipitation is a result of formation of free base on the surface of the dissolving salt. Diffusion Layer modulated (DLM) solids are defined and presented that can effectively counteract this precipitation mechanism. These DLM materials employ excipients in order to modify the pH or solubility conditions at the surface of the dissolving salt to minimize precipitation of the free base that can occur. Rotating disk dissolution data is presented which shows how these formulated solids can act to improve the dissolution profile for these materials.
引用
收藏
页码:1441 / 1449
页数:9
相关论文
共 27 条
[1]  
Adams W J, 1998, Pharm Biotechnol, V11, P285
[2]  
AGUIRREODE F, 1987, J CHEM EDUC, V64, P957
[3]   AN APPROACH FOR THE PREDICTION OF THE INTRINSIC DISSOLUTION RATES OF DRUGS UNDER UNBUFFERED CONDITIONS [J].
ALJANABI, II .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (02) :347-360
[4]   The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder [J].
Avale, ME ;
Falzone, TL ;
Gelman, DM ;
Low, MJ ;
Grandy, DK ;
Rubinstein, M .
MOLECULAR PSYCHIATRY, 2004, 9 (07) :718-726
[5]   Miniaturized rotating disk intrinsic dissolution rate measurement: Effects of buffer capacity in comparisons to traditional Wood's apparatus [J].
Avdeef, Alex ;
Tsinman, Oksana .
PHARMACEUTICAL RESEARCH, 2008, 25 (11) :2613-2627
[6]   Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389 [J].
Badawy, SIF ;
Gray, DB ;
Zhao, F ;
Sun, DX ;
Schuster, AE ;
Hussain, MA .
PHARMACEUTICAL RESEARCH, 2006, 23 (05) :989-996
[7]   Solid phases of delavirdine mesylate [J].
Bergren, MS ;
Chao, RS ;
Meulman, PA ;
Sarver, RW ;
Lyster, MA ;
Havens, JL ;
Hawley, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (08) :834-841
[8]  
Bighley LD., 1996, ENCY PHARM TECHNOLOG, V13, P453
[9]   THE HYDROLYSIS OF SALTS DERIVED FROM A WEAK MONOPROTIC ACID AND A WEAK MONOPROTIC BASE - SOME CRITICAL REMARKS [J].
CARDINALI, ME ;
GIOMINI, C ;
MARROSU, G .
JOURNAL OF CHEMICAL EDUCATION, 1990, 67 (03) :221-223
[10]   Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model [J].
Carino, SR ;
Sperry, DC ;
Hawley, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (01) :116-125